Silence Therapeutics plc (SLN): Shareholders' Equity
$62.30M
As of 2025-12-31
$38.47M
As of 2026-06-30
+31.8%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $62.30M | -53.5% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $134.02M | +509.4% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $21.99M | -19.2% | 2026-03-05, Balance as of period end |
| 2022-12-31 | $27.22M | n/a | 2025-02-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Silence Therapeutics plc (SLN) | 2025-12-31 | $62.30M | -53.5% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $27.77M | -46.7% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $641.6K | -89.3% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$2.49M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$95.46M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$1.22M | n/m |
Compare SLN, YARW, QUCY, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗